This is a routine office lease for new headquarters with no impact on the company's pipeline or financial outlook. Monitor for any future updates on operational milestones or clinical data that could affect the stock.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Aug 26 $24.73entry
- T+1 · 3mo ago +0.40%α −0.25% · $24.83
- T+5 · 3mo ago −4.73%α −4.61% · $23.56
- T+20 · 8w ago −20.02%α −20.24% · $19.78
- T+57 · todayOpen
- T+60 · in 2d Pending
Price Chart
How similar events traded
Executive Summary
Bicara Therapeutics entered into a sub-sublease agreement with Wayfair LLC for approximately 35,090 square feet of office space at 10 St. James Avenue, Boston, for its new corporate headquarters. The lease runs through September 2028 with base rent of $105,279 per month starting nine months after the commencement date, and a $210,540 security deposit was paid. This is a routine administrative real estate transaction with no material financial impact on the company's operations or stock.
Key Facts
- Bicara Therapeutics sub-leased ~35,090 sq ft of office space at 10 St. James Avenue, Boston from Wayfair LLC.
- The sublease term runs from the later of October 1, 2026 or full consent execution, through September 30, 2028.
- Base rent is $105,279 per month, payable nine months after the Commencement Date.
- A security deposit of $210,540 was paid.
- The space will serve as the company's new corporate headquarters.
Financial Impact
Base rent of $105,279/month (~$1.26M/year) with a $210,540 security deposit. Rent payments begin nine months after the Commencement Date.
Risk Factors
- No material risks identified from this routine real estate transaction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-058937 |
| Document: 0001628280-26-058937-index.html | 0001628280-26-058937 |
| Document: 0001628280-26-058937.txt | 0001628280-26-058937 |
Track record
26 reports on BCAX
1 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +5.65% at T+20 after the Apr 15, 2026 report. 1 of 3 went positive at some point.
Filters
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $9.98 Now $9.75 −2.30% settles Dec 8
- Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $8.89 Now $9.75 +9.67% settles Dec 3
- Nov 4, 202612d ago Press Release Neutral 2/10 Entry $8.89 Now $9.75 +9.67% settles Dec 3
- Oct 7, 20265w ago SC 13G/A Neutral 3/10 Entry $16.42 to $8.89 Now $9.75 −40.62% ▼ −45.86% −44.52% vs SPY
- Oct 5, 20266w ago Press Release Neutral 2/10 Entry $17.29 to $9.13 Now $9.75 −43.61% ▼ −47.19% −44.73% vs SPY
- Sep 22, 20267w ago Institutional Cluster Bullish 4/10 Entry $22.78 to $18.35 Now $9.75 −57.20% ▼ −19.45% −18.89% vs SPY
- Aug 25, 202611w ago 8-K Neutral 2/10 Viewing Entry $24.73 to $19.78 Now $9.75 −60.57% ▼ −20.02% −20.24% vs SPY
- Aug 14, 202613w ago Press Release Neutral 2/10 Entry $24.28 to $23.20 Now $9.75 −59.84% ▼ −4.45% −2.46% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral Not scored Entry $23.63 to $22.81 Now $9.75 −58.74% ▼ −3.47% −1.72% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $23.63 to $22.81 Now $9.75 −58.74% ▼ −3.47% −1.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers